Mumbai: Global private equity fund Carlyle is in talks to buy a significant minority stake in Indegene Lifesystems, a healthcare IT firm backed by NS Raghavan, for $ 140 million, said three people with first-hand knowledge of the development. That offer values the company in the $ 500-600 million range.

The total fundraise is being pegged for approximately $ 190-200 million, with $ 140 million were from Carlisle and the remaining from other investors.

A person familiar with knowledge of the development said: "Fundraising, which is one of the  largest in the sector globally, includes both primary and secondary components."

An announcement is expected later this week.

Initially, the company had the support of the KITVEN Fund. Indegene has been in talks with global fund BCP Partners to co-invest. On the back of the Carlyle investment, it to is expected to on-board the company.

Indegene Lifesystems and Carlyle declined to comment.

Bengaluru-based Indegene co-founder, Manish Gupta, IIT-BHU and IIM Ahmedabad graduate, who worked for Infosys up to 1998, and four others. The company helps US-based life sciences companies in the United States with analytics, technology, operations, and medical expertise (ATOM).

Also Read: India may have a New Central Bank Digital Currency, the Reserve Bank of India is exploring the possibility